
Avery Dennison (AVY) Stock Forecast & Price Target
Avery Dennison (AVY) Analyst Ratings
Bulls say
Avery Dennison is projected to experience robust growth in its Intelligent Labels (IL) segment, with anticipated increases of 10-15% in 2025, driven particularly by active program expansions and new customer adoptions. The company's strategic partnerships, such as the recent collaboration with CVS Health, are expected to bolster revenue through enhanced solutions offerings, contributing to high single-digit to low double-digit percentage growth. Additionally, the company's focus on improving solutions margins and maintaining a strong balance sheet underpins its capability for disciplined capital allocation, with expectations for acceleration in earnings per share (EPS) growth throughout the year.
Bears say
Avery Dennison's stock outlook is negatively influenced by a decline in enterprise-wide sales, attributed to weaker logistics volumes despite modest growth in specific segments such as apparel and general retail. The company has guided for lower-than-expected organic sales growth for 2025, along with reported operating EPS of $2.38, which has heightened concerns about execution on cost savings and overall demand fluctuations. Additionally, risks associated with commodity price volatility, integration of acquisitions, and increasing competition further exacerbate the financial uncertainties facing the company.
This aggregate rating is based on analysts' research of Avery Dennison and is not a guaranteed prediction by Public.com or investment advice.
Avery Dennison (AVY) Analyst Forecast & Price Prediction
Start investing in Avery Dennison (AVY)
Order type
Buy in
Order amount
Est. shares
0 shares